Abstract
Background
The physiopathologies of many neurologic diseases are characterized by related biochemical dysfunctions that could be explored as drug targets. This study evaluated the effect of a methanol leaf extract of Antiaris africana (MEA) on critical bioindices of Parkinsonism and related neurologic dysfunctions in rats with rotenone-induced neurotoxicity.
Methods
Animals were administered 50 or 100 mg/kg MEA for 14 consecutive days. Rotenone (1.5 mg/kg) was administered three times per day on days 13 and 14. Coenzyme Q10 (5 mg/kg) was the reference drug. Complex I activity, dopamine level, activities of acetylcholinesterase, myeloperoxidase, Na+/K+ ATPase and glutamine synthetase, as well as oxidative stress indices were evaluated at the end of the period of treatment.
Results
Rotenone-intoxicated group showed disruption of complex 1 activity, dopamine level, and glutamine synthetase activity with negative alterations to activities of acetylcholinesterase, myeloperoxidase, and Na+/K+ ATPase as well as heightened cerebral oxidative stress. MEA restored brain mitochondria functionality, mitigated altered neurochemical integrity, and ameliorated cerebral oxidative stress occasioned by rotenone neurotoxicity. The activity of A. Africana was comparable with that of 5 mg/kg coenzyme Q10.
Conclusions
These results indicated that A. africana displayed therapeutic potential against Parkinsonism and related neurologic dysfunctions and support its ethnobotanical use for the treatment of neurologic disorders.
Research funding: None declared.
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Competing interests: Authors state no conflict of interest.
Ethical approval: Research involving animals complied with all relevant national regulations and institutional policies and with NIH Guide for the Care and Use of Laboratory Animals, 2011.
References
[1] GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 2017;16:877–97.10.1016/S1474-4422(17)30299-5Search in Google Scholar
[2] Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Time trends in the incidence of Parkinson disease. JAMA Neurol 2016;73:981.10.1001/jamaneurol.2016.0947Search in Google Scholar PubMed PubMed Central
[3] Fedeli U, Schievano E. Increase in Parkinson’s disease-related mortality among males in Northern Italy. Parkinsonism Relat Disord 2017;40:47–50.10.1016/j.parkreldis.2017.04.008Search in Google Scholar PubMed
[4] Mathew T, Nadimpally US, Prabhu AD, Nadig R. Drug-induced Parkinsonism on the rise: beware of levosulpiride and its combinations with proton pump inhibitors. Neurol India 2017;65:173–4.10.4103/0028-3886.198175Search in Google Scholar PubMed
[5] Tonda-Turo C, Origlia N, Mattu C, Accorroni A, Chiono V. Current limitations in the treatment Parkinson’s and Alzheimer’s diseases: state-of-the-art and future perspective of polymeric carriers. Curr Med Chemi 2018;25:5755–71.10.2174/0929867325666180221125759Search in Google Scholar PubMed
[6] Maldonado PD, Chánez-Cárdenas ME, Fernández-López A. Mechanisms of cell damage in neurological diseases and putative neuroprotective strategies. Oxid Med Cell Longev 2018;2018:9784319.10.1155/2018/9784319Search in Google Scholar PubMed PubMed Central
[7] Janssen AJ, Trijbels FJ, Sengers RC, Smeitink JA, van den Heuvel LP, Wintjes LT, et al. Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin Chem 2007;53:729–34.10.1373/clinchem.2006.078873Search in Google Scholar PubMed
[8] Hu Q, Wang G. Mitochondrial dysfunction in Parkinson’s disease. Transl Neurodegener 2016;5:14.10.1186/s40035-016-0060-6Search in Google Scholar PubMed PubMed Central
[9] Sherer TB, Kim JH, Betarbet R, Greenamyre JT. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 2003;179:9–16.10.1006/exnr.2002.8072Search in Google Scholar PubMed
[10] Jayakumar AR, Norenberg MD. Glutamine synthetase: role in neurological disorders. Adv Neurobiol 2016;13:327–50.10.1007/978-3-319-45096-4_13Search in Google Scholar PubMed
[11] Holm TH, Lykke-Hartmann K. Insights into the pathology of the α3 Na+/K+-ATPase ion pump in neurological disorders; lessons from animal models. Front Physiol 2016;7:209.10.3389/fphys.2016.00209Search in Google Scholar
[12] Clausen MV, Hilbers F, Poulsen H. The structure and function of the Na,K-ATPase isoforms in health and disease. Front Physiol 2017;8:371.10.3389/fphys.2017.00371Search in Google Scholar
[13] Ilesanmi OB, Olaleye TM, Akinmoladun AC, Alawode TT. HPLC quantification of phenolic content and assessment of methanolic extract of Antiaris africana for toxicological study. Afr J Biotechnol 2016;15:320–30.10.5897/AJB2015.14825Search in Google Scholar
[14] Olufunke MD, Zaki FU. Chemical constituents of the leaf, stem-bark and root essential oils of Antiaris africana. J Appl Pharm Sci 2013;3:168–71.Search in Google Scholar
[15] Guo L, Zhang Y, Li Q. Spectrophotometric determination of dopamine hydrochloride in pharmaceutical, banana, urine and serum samples by potassium ferricyanide-Fe(III). Anal Sci 2009;25:1451–5.10.2116/analsci.25.1451Search in Google Scholar
[16] Ellman GL, Courtney KD, Andres V, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.10.1016/0006-2952(61)90145-9Search in Google Scholar
[17] Shults CW, Nasirian F, Ward DM, Nakano K, Pay M, Hill LR, et al. Carbidopa/levodopa and selegiline do not affect platelet mitochondrial function in early parkinsonism. Neurology 1995;45:344–8.10.1212/WNL.45.2.344Search in Google Scholar
[18] Sunil AG, Kesavanarayanan KS, Kalaivani P, Sathiya S, Ranju V, Priya RJ, et al. Total oligomeric flavonoids of Cyperus rotundus ameliorates neurological deficits, excitotoxicity and behavioral alterations induced by cerebral ischemic-reperfusion injury in rats. Brain Res Bull 2011;84:394–405.10.1016/j.brainresbull.2011.01.008Search in Google Scholar
[19] Misra HP, Fridovich I. The univalent reduction of oxygen by reduced flavins and quinones. J Biol Chem 1972;247:188–92.10.1016/S0021-9258(19)45773-6Search in Google Scholar
[20] Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130–9.10.1016/S0021-9258(19)42083-8Search in Google Scholar
[21] Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393–7.10.1038/34923Search in Google Scholar PubMed
[22] Varshney R, Kale RK. Effects of calmodulin antagonists on radiation-induced lipid peroxidation in microsomes. Int J Radiat Biol 1990;58:733–43.10.1080/09553009014552121Search in Google Scholar PubMed
[23] Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther 1973;187:195–202.Search in Google Scholar
[24] Schuler F, Casida JE. The insecticide target in the PSST subunit of complex I. Pest Manag Sci 2001;57:932–40.10.1002/ps.364Search in Google Scholar PubMed
[25] Papa S, Rasmo DD. Complex I deficiencies in neurological disorders. Trends Mol Med 2013;19:61–9.10.1016/j.molmed.2012.11.005Search in Google Scholar PubMed
[26] Neves Carvalho A, Firuzi O, Joao Gama M, van Horssen J, Saso L. Oxidative stress and antioxidants in neurological diseases: is there still hope? Curr Drug Targets 2017;18:705–18.10.2174/1389450117666160401120514Search in Google Scholar PubMed
[27] Zaitone SA, Abo-Elmatty DM, Shaalan AA. Acetyl-l-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson’s disease therapy. Pharmacol Biochem Behav 2012;100:347–60.10.1016/j.pbb.2011.09.002Search in Google Scholar PubMed
[28] Danbolt NC, Furness DN, Zhou Y. Neuronal vs glial glutamate uptake: resolving the conundrum. Neurochem Int 2016;98:29–45.10.1016/j.neuint.2016.05.009Search in Google Scholar PubMed
[29] Bos IW, Hoogland G, Meine Jansen CF, Willigen Gv, Spierenburg HA, van den Berg LH, et al. Increased glutamine synthetase but normal EAAT2 expression in platelets of ALS patients. Neurochem Int 2006;48:306–11.10.1016/j.neuint.2005.09.009Search in Google Scholar PubMed
[30] Babu CS, Ramanathan M. Pre-ischemic treatment with memantine reversed the neurochemical and behavioural parameters but not energy metabolites in middle cerebral artery occluded rats. Pharmacol Biochem Behav 2009;92:424–32.10.1016/j.pbb.2009.01.010Search in Google Scholar PubMed
[31] Babu CS, Ramanathan M. Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity, neurobehavioural alterations and partially the bioenergetics. Int J Dev Neurosci 2011;29:93–105.10.1016/j.ijdevneu.2010.08.001Search in Google Scholar PubMed
[32] Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodzki RM, Beleslin-Cokic B, et al. Erythropoietin receptor signalling is required for normal brain development. Development 2002;129:505–16.10.1242/dev.129.2.505Search in Google Scholar PubMed
[33] Poon HF, Calabrese V, Scapagnini G, Butterfield DA. Free radicals and brain aging. Clin Geriatr Med 2004;20:329–59.10.1016/j.cger.2004.02.005Search in Google Scholar PubMed
[34] Aksenov MY, Aksenova MV, Carney JM, Buterfield DA. Oxidative modification of glutamine synthetase by amyloid beta peptide. Free Radic Res 1997;27:267–81.10.3109/10715769709065765Search in Google Scholar PubMed
[35] Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, et al. Brain regional correspondence between Alzheimer’s disease histopathology and biomarkers of protein oxidation. J Neurochem 1995;65:2146–56.10.1046/j.1471-4159.1995.65052146.xSearch in Google Scholar PubMed
[36] Prado MA, Marchot P, Silman I. Preface: cholinergic mechanisms. J Neurochem 2017;142:3–6.10.1111/jnc.14027Search in Google Scholar PubMed
[37] Han Y, Zhang T, Su J, Zhao Y, Chenchen, Wang, et al. Apigenin attenuates oxidative stress and neuronal apoptosis in early brain injury following subarachnoid hemorrhage. J Clin Neurosci 2017;40:157–62.10.1016/j.jocn.2017.03.003Search in Google Scholar PubMed
[38] Lehner KR, Silverman HA, Addorisio ME, Roy A, Al-Onaizi MA, Levine Y, et al. Forebrain cholinergic signaling regulates innate immune responses and inflammation. Front Immunol 2019;10:585.10.3389/fimmu.2019.00585Search in Google Scholar PubMed PubMed Central
© 2020 Walter de Gruyter GmbH, Berlin/Boston
